Advanced search
Publication Cover
Journal of Asthma Volume 45, 2008 - Issue 2
Submit an article Journal homepage
259
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Churg-Strauss Vasculitis in a Patient Treated with Omalizumab

Elana Bargagli Respiratory Diseases Section, Department of Clinical Medicine and Immunology, Siena University, Siena, Italy
,
Chiara Madioni Respiratory Diseases Section, Department of Clinical Medicine and Immunology, Siena University, Siena, Italy
,
Carmela Olivieri Respiratory Diseases Section, Department of Clinical Medicine and Immunology, Siena University, Siena, Italy
,
Francesco Penza Respiratory Diseases Section, Department of Clinical Medicine and Immunology, Siena University, Siena, Italy
&
Paola Rottoli Respiratory Diseases Section, Department of Clinical Medicine and Immunology, Siena University, Siena, Italy
Pages 115-116 | Published online: 02 Jul 2009

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Justin C. Chia & P. Régine Mydlarski. (2017) Dermatologic uses of omalizumab. Journal of Dermatological Treatment 28:4, pages 332-337.
Read now
Girolamo Pelaia, Luca Gallelli, Teresa Renda, Pasquale Romeo, Maria Teresa Busceti, Rosa Daniela Grembiale, Rosario Maselli, Serafino Antonio Marsico & Alessandro Vatrella. (2011) Update on optimal use of omalizumab in management of asthma. Journal of Asthma and Allergy 4, pages 49-59.
Read now
Ricardo Tan & Jonathan Corren. (2011) Omalizumab in the treatment of asthma. Expert Review of Respiratory Medicine 5:6, pages 747-756.
Read now
Ricardo A Tan & Jonathan Corren. (2011) Safety of omalizumab in asthma. Expert Opinion on Drug Safety 10:3, pages 463-471.
Read now
Dennis Keith Ledford. (2009) Omalizumab: overview of pharmacology and efficacy in asthma. Expert Opinion on Biological Therapy 9:7, pages 933-943.
Read now

Articles from other publishers (35)

Alejandra Carrón-Herrero, Corrado Pelaia & Giovanni Paoletti. (2023) New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis. Exploration of Asthma & Allergy, pages 31-48.
Crossref
Vincent Cottin. (2023) Eosinophilic Lung Diseases. Immunology and Allergy Clinics of North America 43:2, pages 289-322.
Crossref
Vincent Cottin. 2023. Orphan Lung Diseases. Orphan Lung Diseases 277 309 .
Ksenia O. Shnaider, Maksim L. Maksimov & Boris K. Romanov. (2022) Safety of omalizumab in the treatment of moderate-to-severe bronchial asthma. Medical Journal of the Russian Federation 28:1, pages 89-98.
Crossref
Yu‐Hsuan Chen & Ping‐Hung Kuo. (2021) Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis. Respirology Case Reports 10:1.
Crossref
Yuni Yamaki, Daisuke Hayashi, Keiji Honda, Hironori Imai & Hidetoshi Takada. (2021) A case of omalizumab‐associated eosinophilic granulomatosis with polyangiitis. Pediatrics International 63:9, pages 1119-1121.
Crossref
Luke Nessan Carson, Ashish Pradhan & Deepak Subramanian. (2021) Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?. BMJ Case Reports 14:7, pages e240078.
Crossref
Debdeep Mitra, Ajay Chopra, Neerja Saraswat, Barnali Mitra, Krishna Talukdar & Reetu Agarwal. (2020) Biologics in dermatology: Off-label indications. Indian Dermatology Online Journal 11:3, pages 319.
Crossref
Vincent Cottin, Kais Ahmad, Mouhamad Nasser, Claudia Valenzuela, Matthieu Groh, Benjamin Terrier & Julie Traclet. 2019. Pulmonary Manifestations of Systemic Diseases. Pulmonary Manifestations of Systemic Diseases 188 209 .
Zheng-Hao Huang, San-Yuan Kuo, Yu-Hsiang Chiu, Hsiang-Cheng Chen & Chun-Chi Lu. (2018) Treatment of multiple refractory ankle ulcerations in thromboangiitis obliterans. Medicine 97:20, pages e10798.
Crossref
Corrado Pelaia, Cecilia Calabrese, Rosa Terracciano, Francesco de Blasio, Alessandro Vatrella & Girolamo Pelaia. (2018) Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness. Therapeutic Advances in Respiratory Disease 12, pages 175346661881019.
Crossref
Santhosh Kumar, Brant R. Ward & Anne-Marie Irani. (2017) Future Prospects of Biologic Therapies for Immunologic Diseases. Immunology and Allergy Clinics of North America 37:2, pages 431-448.
Crossref
Salik Nazir, Niranjan Tachamo, Shoaib Bilal Fareedy, Muhammad Sohail Khan & Saroj Lohani. (2017) Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Annals of Allergy, Asthma & Immunology 118:3, pages 372-374.e1.
Crossref
Girolamo Pelaia, Alessandro Vatrella & Rosario MaselliGirolamo Pelaia, Alessandro Vatrella & Rosario Maselli. 2017. Asthma: Targeted Biological Therapies. Asthma: Targeted Biological Therapies 27 49 .
R.P. Cusack, A. Sahadevan & S.J. Lane. (2016) Qualitative effects of omalizumab on concomitant IgE-mediated disease in a severe asthmatic population: a real life observational study. QJM 109:9, pages 601-604.
Crossref
Vincent Cottin. (2016) Eosinophilic Lung Diseases. Clinics in Chest Medicine 37:3, pages 535-556.
Crossref
Marie Jachiet, Maxime Samson, Vincent Cottin, Jean-Emmanuel Kahn, Guillaume Le Guenno, Philippe Bonniaud, Hervé Devilliers, Laurence Bouillet, Anne Gondouin, Fatma Makhlouf, Nadine Meaux-Ruault, Helder Gil, Boris Bienvenu, André Coste, Matthieu Groh, Violaine Giraud, Stéphane Dominique, Bertrand Godeau, Xavier Puéchal, Chahera Khouatra, Marc Ruivard, Claire Le Jeunne, Luc Mouthon, Loïc Guillevin & Benjamin Terrier. (2016) Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients. Arthritis & Rheumatology 68:9, pages 2274-2282.
Crossref
David El-Qutob. (2015) Off-Label Uses of Omalizumab. Clinical Reviews in Allergy & Immunology 50:1, pages 84-96.
Crossref
Vincent Cottin & Jean-François Cordier. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine 1221 1242.e13 .
O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis & F. Spertini. (2015) EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70:7, pages 727-754.
Crossref
Harold P. AdamsJr.Jr.. 2014. Neurologic Aspects of Systemic Disease Part I. Neurologic Aspects of Systemic Disease Part I 475 494 .
Vincent Cottin & Jean-François Cordier. (2012) Eosinophilic Lung Diseases. Immunology and Allergy Clinics of North America 32:4, pages 557-586.
Crossref
Cezmi A Akdis. (2012) Therapies for allergic inflammation: refining strategies to induce tolerance. Nature Medicine 18:5, pages 736-749.
Crossref
Jennifer Ramsey, Mohammed Amari & Stephen P. Kantrow. (2010) Pulmonary Vasculitis: Clinical Presentation, Differential Diagnosis, and Management. Current Rheumatology Reports 12:6, pages 420-428.
Crossref
J. Vinit, P. Bielefeld, G. Muller, P. Pfitzenmeyer, P. Bonniaud, B. Lorcerie & J.F. Besancenot. (2010) Heart involvement in Churg–Strauss syndrome: Retrospective study in French Burgundy population in past 10years. European Journal of Internal Medicine 21:4, pages 341-346.
Crossref
Vincent Cottin & Jean-François Cordier. 2010. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine 1469 1495 .
M. Cazzola, M. Mura, A. Segreti, M. A. Mattei & P. Rogliani. (2009) Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome? . Allergy 64:9, pages 1389-1390.
Crossref
Maria Francesca Spina & Antonio Miadonna. (2009) Role of omalizumab and steroids in Churg-Strauss syndrome. Journal of Allergy and Clinical Immunology 124:3, pages 600-601.
Crossref
Michael E. Wechsler, Dennis A. Wong, Mary K. Miller & Lisa Lawrence-Miyasaki. (2009) Churg-Strauss Syndrome in Patients Treated With Omalizumab. Chest 136:2, pages 507-518.
Crossref
Renato A. Sinico & Paolo Bottero. (2009) Churg–Strauss angiitis. Best Practice & Research Clinical Rheumatology 23:3, pages 355-366.
Crossref
M. Martinez Del Pero & P. Sivasothy. (2009) Vasculitis of the upper and lower airway. Best Practice & Research Clinical Rheumatology 23:3, pages 403-417.
Crossref
. (2009) Current World Literature. Current Opinion in Rheumatology 21:1, pages 85-92.
Crossref
Girolamo PelaiaTeresa Renda, Pasquale Romeo, Maria Teresa Busceti & Rosario Maselli. (2008) Review: Omalizumab in the treatment of severe asthma: efficacy and current problems. Therapeutic Advances in Respiratory Disease 2:6, pages 409-421.
Crossref
Rafael G. Grau. (2009) Churg-Strauss syndrome: 2005–2008 update. Current Rheumatology Reports 10:6, pages 453-458.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.